Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lartigau

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1995
[Is "pulse dose rate" curietherapy comparable to low dose rate brachytherapy?]E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 29, 1999
[Radiation sensitizing agents for hypoxic cells: past, present and future]E Lartigau
Therapie|January 25, 2002
[Tissue hypoxia, tumor angiogenesis and radiotherapy]E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 1, 1997
[From biology to radiotherapy: current state and future perspectives]E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 3, 2010
[Reirradiation of head and neck cancers]B Comet, E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 6, 2010
[Therapeutic index in radiotherapy and patient information]S Dewas, E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 22, 2009
[Risk analysis in radiotherapy]P Francois, E Lartigau
Current Opinion in Oncology|June 1, 1990
Radiotherapy and combined chemoradiotherapy in head and neck carcinomaF Eschwege, E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 1, 2005
[Anaemia and radiation therapy]F Denis, E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 26, 2004
[Comment on the article by M. Henke: "Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomized, double blind, placebo controlled trial" or how a cytokine remains a cytokine]E Lartigau, F Denis
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1995
[Is "pulse dose rate" curietherapy comparable to low dose rate brachytherapy?]E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 29, 1999
[Radiation sensitizing agents for hypoxic cells: past, present and future]E Lartigau
Therapie|January 25, 2002
[Tissue hypoxia, tumor angiogenesis and radiotherapy]E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 1, 1997
[From biology to radiotherapy: current state and future perspectives]E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 3, 2010
[Reirradiation of head and neck cancers]B Comet, E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 6, 2010
[Therapeutic index in radiotherapy and patient information]S Dewas, E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 22, 2009
[Risk analysis in radiotherapy]P Francois, E Lartigau
Current Opinion in Oncology|June 1, 1990
Radiotherapy and combined chemoradiotherapy in head and neck carcinomaF Eschwege, E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 1, 2005
[Anaemia and radiation therapy]F Denis, E Lartigau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 26, 2004
[Comment on the article by M. Henke: "Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomized, double blind, placebo controlled trial" or how a cytokine remains a cytokine]E Lartigau, F Denis
Pageof 14